Defining Misprescribing to Inform Prescription Opioid Policy

Research output: Contribution to journalComment/debate

Abstract

Prescription opioid policies too often reflect over a century's worth of moralizing about the nature of opioid use disorder, the value of pain, and the meaning of suffering. The social and legal penalties to prescribers run in one direction—avoid overprescribing, however defined, at all costs. The lack of shared definitions is problematic for formulating and evaluating opioid policy. For example, the variant definitions of “misuse,” “abuse,” and “addiction” complicate estimates of morbidity. There are also no widely accepted definitions of misprescribing and overprescribing. I offer here a modest attempt at the categorization of misprescribing: inadvertent overprescribing, corrupt overprescribing, qualitative overprescribing, quantitative overprescribing, multiclass overprescribing, and underprescribing.

Original languageEnglish (US)
Pages (from-to)5-6
Number of pages2
JournalHastings Center Report
Volume48
Issue number4
DOIs
StatePublished - Jul 1 2018

Fingerprint

Opioid Analgesics
Prescriptions
medication
Somatoform Disorders
Psychological Stress
addiction
morbidity
pain
penalty
abuse
Morbidity
Costs and Cost Analysis
lack
costs
Prescription
Values
Addiction
Costs
Abuse
Pain

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Issues, ethics and legal aspects
  • Philosophy
  • Health Policy

Cite this

Defining Misprescribing to Inform Prescription Opioid Policy. / Dineen, Kelly K.

In: Hastings Center Report, Vol. 48, No. 4, 01.07.2018, p. 5-6.

Research output: Contribution to journalComment/debate

@article{9f03100df6fb48ebb966bb68441d8555,
title = "Defining Misprescribing to Inform Prescription Opioid Policy",
abstract = "Prescription opioid policies too often reflect over a century's worth of moralizing about the nature of opioid use disorder, the value of pain, and the meaning of suffering. The social and legal penalties to prescribers run in one direction—avoid overprescribing, however defined, at all costs. The lack of shared definitions is problematic for formulating and evaluating opioid policy. For example, the variant definitions of “misuse,” “abuse,” and “addiction” complicate estimates of morbidity. There are also no widely accepted definitions of misprescribing and overprescribing. I offer here a modest attempt at the categorization of misprescribing: inadvertent overprescribing, corrupt overprescribing, qualitative overprescribing, quantitative overprescribing, multiclass overprescribing, and underprescribing.",
author = "Dineen, {Kelly K.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1002/hast.862",
language = "English (US)",
volume = "48",
pages = "5--6",
journal = "Hastings Center Report",
issn = "0093-0334",
publisher = "Hastings Center",
number = "4",

}

TY - JOUR

T1 - Defining Misprescribing to Inform Prescription Opioid Policy

AU - Dineen, Kelly K.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Prescription opioid policies too often reflect over a century's worth of moralizing about the nature of opioid use disorder, the value of pain, and the meaning of suffering. The social and legal penalties to prescribers run in one direction—avoid overprescribing, however defined, at all costs. The lack of shared definitions is problematic for formulating and evaluating opioid policy. For example, the variant definitions of “misuse,” “abuse,” and “addiction” complicate estimates of morbidity. There are also no widely accepted definitions of misprescribing and overprescribing. I offer here a modest attempt at the categorization of misprescribing: inadvertent overprescribing, corrupt overprescribing, qualitative overprescribing, quantitative overprescribing, multiclass overprescribing, and underprescribing.

AB - Prescription opioid policies too often reflect over a century's worth of moralizing about the nature of opioid use disorder, the value of pain, and the meaning of suffering. The social and legal penalties to prescribers run in one direction—avoid overprescribing, however defined, at all costs. The lack of shared definitions is problematic for formulating and evaluating opioid policy. For example, the variant definitions of “misuse,” “abuse,” and “addiction” complicate estimates of morbidity. There are also no widely accepted definitions of misprescribing and overprescribing. I offer here a modest attempt at the categorization of misprescribing: inadvertent overprescribing, corrupt overprescribing, qualitative overprescribing, quantitative overprescribing, multiclass overprescribing, and underprescribing.

UR - http://www.scopus.com/inward/record.url?scp=85051651047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051651047&partnerID=8YFLogxK

U2 - 10.1002/hast.862

DO - 10.1002/hast.862

M3 - Comment/debate

AN - SCOPUS:85051651047

VL - 48

SP - 5

EP - 6

JO - Hastings Center Report

JF - Hastings Center Report

SN - 0093-0334

IS - 4

ER -